BioCentury
ARTICLE | Financial News

Chinese immuno-oncology play CStone raises $260M

May 11, 2018 6:12 PM UTC

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised on May 8 $260 million in a series B round led by new investor GIC Private. CStone said the round is the largest series B ever for a Chinese biopharma.

New investors in the round included Sequoia China, Yunfeng Capital, 6 Dimensions Capital, CITIC PE, Taikang Insurance Group, Arch Venture Partners, Hillhouse Capital, King Star Capital, 3W Partners, AVICT and Terra Magnum Capital Partners. Also participating were existing investors Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures...